These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 1097513

  • 1. Cytotoxic activity of lymphocytes. V. Role of soluble toxin in macrophage-inhibited cultures of tumor cells.
    Reed WP, Lucas ZJ.
    J Immunol; 1975 Aug; 115(2):395-404. PubMed ID: 1097513
    [Abstract] [Full Text] [Related]

  • 2. Cytotoxic activity of lymphocytes. II. Studies on mechanism of lymphotoxin-mediated cytotoxicity.
    Walker SM, Lucas ZJ.
    J Immunol; 1972 Dec; 109(6):1233-44. PubMed ID: 5086236
    [No Abstract] [Full Text] [Related]

  • 3. Cytotoxicity mediated by soluble macrophage product(s).
    Sethi KK, Brandis H.
    J Natl Cancer Inst; 1975 Aug; 55(2):393-5. PubMed ID: 808640
    [Abstract] [Full Text] [Related]

  • 4. Rat macrophage-mediated toxicity to cancer cells; effect of endotoxins and endotoxin inhibitors contained in culture media.
    Martin F, Martin M, Jeannin JF, Lagneau A.
    Eur J Immunol; 1978 Aug; 8(8):607-11. PubMed ID: 699956
    [Abstract] [Full Text] [Related]

  • 5. Tumor target-derived soluble factor synergizes with IFN-gamma and IL-2 to activate macrophages for tumor necrosis factor and nitric oxide production to mediate cytotoxicity of the same target.
    Jiang H, Stewart CA, Fast DJ, Leu RW.
    J Immunol; 1992 Sep 15; 149(6):2137-46. PubMed ID: 1517576
    [Abstract] [Full Text] [Related]

  • 6. Target cell destruction in vitro by concanavalin A-stimulated lymphoid cells.
    Schwartz HJ, Wilson F.
    Am J Pathol; 1971 Aug 15; 64(2):295-304. PubMed ID: 5142268
    [Abstract] [Full Text] [Related]

  • 7. Macrophages activated in vitro with lymphocyte mediators kill neoplastic but not normal cells.
    Piessens WF, Churchill WH, David.
    J Immunol; 1975 Jan 15; 114(1 Pt 2):293-9. PubMed ID: 163856
    [Abstract] [Full Text] [Related]

  • 8. Rat lung macrophage tumor cytotoxin production: impairment by chronic in vivo cigarette smoke exposure.
    Flick DA, Gonzalez-Rothi RJ, Harris JO, Gifford GE.
    Cancer Res; 1985 Nov 15; 45(11 Pt 1):5225-9. PubMed ID: 2413988
    [Abstract] [Full Text] [Related]

  • 9. Macrophage tumoricidal activity as a possible antitumor mechanism associated with the local injection of allogeneic spleen cells into rats.
    Kawase I, Komuta K, Namba M, Yokota S, Ogura T, Kishimoto S.
    Cancer Res; 1986 Mar 15; 46(3):1047-54. PubMed ID: 3510719
    [Abstract] [Full Text] [Related]

  • 10. Lysis and necrosis: analysis of two cytotoxic phenomena mediated by lymphocytes.
    Ginsburg H, Naot Y, Hollander N.
    Isr J Med Sci; 1976 Mar 15; 12(4-5):435-53. PubMed ID: 59715
    [Abstract] [Full Text] [Related]

  • 11. IL-2 enhances standard IFNgamma/LPS activation of macrophage cytotoxicity to human ovarian carcinoma in vitro: a potential for adoptive cellular immunotherapy.
    Han X, Wilbanks GD, Devaja O, Ruperelia V, Raju KS.
    Gynecol Oncol; 1999 Nov 15; 75(2):198-210. PubMed ID: 10525372
    [Abstract] [Full Text] [Related]

  • 12. B cell stimulatory factor-1 (interleukin 4) activates macrophages for increased tumoricidal activity and expression of Ia antigens.
    Crawford RM, Finbloom DS, Ohara J, Paul WE, Meltzer MS.
    J Immunol; 1987 Jul 01; 139(1):135-41. PubMed ID: 3108395
    [Abstract] [Full Text] [Related]

  • 13. Killer-helper effect of L cells in the generation of anti-MM cytotoxic T lymphocytes: replacement by beta-interferon and mechanisms of action.
    Ishikawa S, Tachibana T.
    Jpn J Cancer Res; 1986 Sep 01; 77(9):931-40. PubMed ID: 2945807
    [Abstract] [Full Text] [Related]

  • 14. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
    Colotta F, Peri G, Villa A, Mantovani A.
    J Immunol; 1984 Feb 01; 132(2):936-44. PubMed ID: 6690624
    [Abstract] [Full Text] [Related]

  • 15. Mechanisms of target cell destruction by alloimmune peritoneal macrophages. II. Release of a specific cytotoxin from interacting cells.
    McIvor KL, Weiser RS.
    Immunology; 1971 Mar 01; 20(3):315-22. PubMed ID: 5102519
    [Abstract] [Full Text] [Related]

  • 16. Studies on macrophage-activating factor (MAF) in antitumor immune responses. I. Tumor-specific Lyt-1+2- T cells are required for producing MAF able to generate cytolytic as well as cytostatic macrophages.
    Nakajima H, Fujiwara H, Takai Y, Izumi Y, Sano S, Tsuchida T, Hamaoka T.
    J Immunol; 1985 Sep 01; 135(3):2199-205. PubMed ID: 3894520
    [Abstract] [Full Text] [Related]

  • 17. Purification of human lymphotoxin.
    Russell SW, Rosenau W, Goldberg ML, Kunitomi G.
    J Immunol; 1972 Oct 01; 109(4):784-90. PubMed ID: 5074332
    [No Abstract] [Full Text] [Related]

  • 18. Identification of macrophage-like characteristics in a cultured murine tumor line.
    Koren HS, Handwerger BS, Wunderlich JR.
    J Immunol; 1975 Feb 01; 114(2 pt 2):894-7. PubMed ID: 1167564
    [Abstract] [Full Text] [Related]

  • 19. Supernatants from ethanol-containing macrophage cultures have cytotoxic activity.
    Wickramasinghe SN.
    Alcohol Alcohol; 1986 Feb 01; 21(3):263-8. PubMed ID: 3464283
    [Abstract] [Full Text] [Related]

  • 20. A simple photometric microassay for the quantitative evaluation of macrophage-mediated cytotoxicity on adherent cancer cells.
    Olsson NO, Leclerc A, Jeannin JF, Martin F.
    Ann Immunol (Paris); 1982 Feb 01; 133D(3):245-54. PubMed ID: 7165278
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.